Interferon Epsilon as a novel regulator of host-bacterial interaction in homeostasis, infection and inflammation [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Gut infections are a leading cause of death worldwide and healthcare use in Australia. Inflammatory bowel disease (IBD) is incurable and affects 1/200 young Australians. Type I interferons (T1IFNs) are important to control gut infections and IBD by interacting with particular bacterial species in the gut. We discovered one T1IFN, IFNε, in human gut. It protects against models of IBD in mice. We will use mouse and human samples to find bacterial or interferon treatments for infections and/or IBD.

Funding Amount $843,088

Funding Scheme Ideas Grants

Chief Investigator Dr Edward Giles

Notes Ideas Grants